TMEM263: a novel candidate gene implicated in human autosomal recessive severe lethal skeletal dysplasia

• Published in: Human genomics 2021-07, Vol.15 (1), p.42-42, Article 42
• Main Authors: Mohajeri, Mahsa Sadat Asl, Eslahi, Atieh, Khazaii, Zeinab, Moradi, Mohammad Reza, Pazhoomand, Reza, Farrokhi, Shima, Feizabadi, Masoumeh Heidari, Alizadeh, Farzaneh, Mojarrad, Majid
• Format: Article
• Language: English
• Subjects: Adult; Animals; Bioinformatics; Bone density; Bone Diseases, Developmental - genetics; Bone Diseases, Developmental - pathology; Bone dysplasia; Bones; Female; Fetus; Fetuses; Fractures; Frameshift mutation; Frameshift Mutation - genetics; Gene discovery; Genes; Genetic counseling; Genetic Predisposition to Disease; Growth Hormone - genetics; Growth Hormone - metabolism; Growth hormones; Homozygote; Humans; Male; Mutation; Nervous system; Novel gene; Pedigree; Physiology; Population; Pregnancy; Primary Research; Proteins; Signal transduction; Signal Transduction - genetics; Skeletal dysplasia; Skeleton; Whole Exome Sequencing
• ISSN: 1479-7364; 1473-9542; 1479-7364
• DOI: 10.1186/s40246-021-00343-2

Skeletal dysplasia is a common, clinically and genetically heterogeneous disorder in the human population. An increasing number of different genes are being identified causing this disorder. We used whole exome sequencing (WES) for detection of skeletal dysplasia causing mutation in a fetus affected to severe lethal skeletal dysplasia. Fetus was assessed by ultrasonography in second trimester of pregnancy. He suffers from severe rhizomelic dysplasia and also pathologic shortening of ribs. WES was applied to finding of causal mutation. Furthermore, bioinformatics analysis was performed to predict mutation impact. Whole exome sequencing (WES) identified a homozygous frameshift mutation in the TMEM263 gene in a fetus with severe lethal skeletal dysplasia. Mutations of this gene have been previously identified in dwarf chickens, but this is the first report of involvement of this gene in human skeletal dysplasia. This gene plays a key role in the growth hormone signaling pathway. TMEM263 can be considered as a new gene responsible for skeletal dysplasia. Given the complications observed in the affected fetus, the mutation of this gene appears to produce much more intense complications than that found in chickens and is likely to play a more important role in bone development in human.